COLLOIDAL OATMEAL

COLLOIDAL OATMEAL was reported 258 times

COLLOIDAL OATMEAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SALIVARY GLAND OPERATION 1 0.0312
1 ENOSTOSIS 1 0.0179
2 NEPHROGENIC FIBROSING DERMOPATHY 3 0.0150
3 SCOLIOSIS SURGERY 1 0.0139
4 MYELOBLAST COUNT INCREASED 1 0.0130
5 PHARYNGO-OESOPHAGEAL DIVERTICULUM 1 0.0110
6 URETERIC INJURY 1 0.0089
7 REPETITIVE STRAIN INJURY 1 0.0088
8 CHOROID MELANOMA 1 0.0088
9 CYSTOPEXY 1 0.0085
10 PARANASAL SINUS MUCOSAL HYPERTROPHY 1 0.0084
11 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
12 SUPERIOR VENA CAVAL OCCLUSION 1 0.0079
13 MEDICAL DEVICE SITE ERYTHEMA 1 0.0078
14 DISSEMINATED COCCIDIOIDOMYCOSIS 1 0.0071
15 TONSILLOLITH 1 0.0071
16 TRACHEAL INJURY 1 0.0068
17 CARDIOLIPIN ANTIBODY POSITIVE 1 0.0055
18 ATONIC URINARY BLADDER 1 0.0052
19 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
20 BENIGN HEPATIC NEOPLASM 1 0.0050
21 SALMONELLA BACTERAEMIA 1 0.0048
22 CONJUNCTIVITIS VIRAL 1 0.0038
23 ANDROGENETIC ALOPECIA 1 0.0035
24 IMPLANT SITE EROSION 1 0.0034
25 CATHETER SITE HAEMATOMA 1 0.0034
26 BIOPSY BREAST 1 0.0032
27 JOINT ABSCESS 1 0.0029
28 VAGINAL FISTULA 1 0.0028
29 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
30 NASAL TURBINATE HYPERTROPHY 1 0.0027
31 PERIPROSTHETIC FRACTURE 1 0.0026
32 ALBUMIN URINE PRESENT 1 0.0026
33 RADIATION OESOPHAGITIS 1 0.0026
34 VIRAL RASH 1 0.0025
35 PHLEBITIS SUPERFICIAL 1 0.0024
36 PSEUDOMONAL BACTERAEMIA 2 0.0023
37 URINARY TRACT INFECTION STAPHYLOCOCCAL 1 0.0023
38 OESOPHAGEAL INFECTION 1 0.0022
39 SKIN FIBROSIS 1 0.0021
40 ECZEMA NUMMULAR 1 0.0020
41 APPLICATION SITE INFECTION 1 0.0020
42 POLYOMAVIRUS VIRAEMIA 2 0.0019
43 INADEQUATE DIET 1 0.0019
44 MEDICAL DEVICE SITE PAIN 1 0.0018
45 INTERNAL FIXATION OF FRACTURE 1 0.0018
46 URINARY TRACT INFECTION FUNGAL 1 0.0017
47 OPHTHALMIC HERPES SIMPLEX 1 0.0017
48 EJECTION FRACTION 1 0.0017
49 TRACHEO-OESOPHAGEAL FISTULA 1 0.0016
50 SICKLE CELL ANAEMIA 1 0.0016
51 SPUTUM ABNORMAL 1 0.0015
52 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
53 MONOCYTE PERCENTAGE INCREASED 1 0.0014
54 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
55 CALCULUS URETERIC 1 0.0014
56 BACTERIAL DISEASE CARRIER 1 0.0014
57 FIBROCYSTIC BREAST DISEASE 1 0.0014
58 WOUND DRAINAGE 1 0.0013
59 HAPTOGLOBIN DECREASED 1 0.0012
60 ADRENAL MASS 1 0.0012
61 FUNGAL SEPSIS 1 0.0012
62 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
63 BLOOD PROLACTIN ABNORMAL 1 0.0012
64 GASTROINTESTINAL FISTULA 1 0.0011
65 BLOOD ALBUMIN INCREASED 1 0.0011
66 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
67 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
68 BONE GRAFT 1 0.0011
69 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
70 VASCULAR PAIN 1 0.0010
71 EPIDERMAL NECROSIS 1 0.0010
72 OEDEMA MUCOSAL 1 0.0010
73 CARPAL TUNNEL DECOMPRESSION 1 0.0009
74 ENTEROCOCCAL BACTERAEMIA 1 0.0009
75 HAEMOGLOBINURIA 1 0.0009
76 T-CELL LYMPHOMA 1 0.0009
77 PELVIC ABSCESS 1 0.0009
78 APPLICATION SITE DISCHARGE 1 0.0009
79 ESCHERICHIA BACTERAEMIA 2 0.0008
80 BILE DUCT STENOSIS 1 0.0008
81 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 1 0.0008
82 CHRONIC RESPIRATORY FAILURE 1 0.0008
83 MONOCYTE COUNT DECREASED 1 0.0008
84 BLADDER PROLAPSE 1 0.0008
85 STEM CELL TRANSPLANT 2 0.0008
86 NASAL PRURITUS 1 0.0008
87 BRONCHIAL SECRETION RETENTION 1 0.0008
88 DACRYOSTENOSIS ACQUIRED 1 0.0008
89 CALCIUM DEFICIENCY 1 0.0008
90 ANAEMIA POSTOPERATIVE 1 0.0008
91 CARBON DIOXIDE INCREASED 1 0.0007
92 FRACTURE NONUNION 1 0.0007
93 APPLICATION SITE INFLAMMATION 1 0.0007
94 BRONCHIAL OBSTRUCTION 1 0.0007
95 PELVIC VENOUS THROMBOSIS 1 0.0007
96 INVESTIGATION ABNORMAL 1 0.0007
97 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
98 CHOLANGIOCARCINOMA 1 0.0007
99 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
100 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
101 CALCULUS URINARY 1 0.0006
102 COAGULATION TIME PROLONGED 1 0.0006
103 OVARIAN CANCER RECURRENT 1 0.0006
104 RENAL CELL CARCINOMA 3 0.0006
105 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
106 ENTEROBACTER INFECTION 1 0.0006
107 SALMONELLOSIS 1 0.0006
108 BLOOD CHLORIDE INCREASED 1 0.0006
109 MEDICAL DEVICE REMOVAL 1 0.0006
110 JUGULAR VEIN THROMBOSIS 1 0.0006
111 PNEUMOMEDIASTINUM 1 0.0006
112 BODY TEMPERATURE ABNORMAL 1 0.0005
113 DIFFUSE ALOPECIA 1 0.0005
114 BLADDER SPASM 1 0.0005
115 PROTEIN TOTAL DECREASED 2 0.0005
116 HYPERCOAGULATION 1 0.0005
117 OCCULT BLOOD POSITIVE 1 0.0005
118 PNEUMONIA FUNGAL 2 0.0005
119 POLYDIPSIA 2 0.0005
120 HYPERPHAGIA 2 0.0005
121 HYPOPHYSITIS 1 0.0005
122 DEVICE RELATED SEPSIS 1 0.0005
123 DERMATITIS PSORIASIFORM 1 0.0005
124 INTRAMEDULLARY ROD INSERTION 1 0.0005
125 SKIN INDURATION 1 0.0005
126 ATRIAL TACHYCARDIA 1 0.0005
127 NEUROGENIC BLADDER 1 0.0005
128 LICHENOID KERATOSIS 1 0.0004
129 BILIRUBIN CONJUGATED INCREASED 1 0.0004
130 VITILIGO 1 0.0004
131 RETINAL TEAR 1 0.0004
132 APPLICATION SITE SWELLING 2 0.0004
133 VEIN DISORDER 2 0.0004
134 HYPERPARATHYROIDISM SECONDARY 1 0.0004
135 URINARY TRACT INFECTION BACTERIAL 1 0.0004
136 SEDATION COMPLICATION 1 0.0004
137 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
138 HERNIA REPAIR 1 0.0004
139 BLOOD ALBUMIN DECREASED 3 0.0004
140 PROTEIN TOTAL INCREASED 1 0.0004
141 MIGRAINE WITH AURA 1 0.0004
142 RED BLOOD CELL COUNT INCREASED 1 0.0004
143 RASH MORBILLIFORM 1 0.0004
144 CHOLECYSTITIS INFECTIVE 1 0.0004
145 DRUG TOLERANCE DECREASED 1 0.0004
146 SKIN HYPERTROPHY 1 0.0004
147 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
148 EYELID MARGIN CRUSTING 1 0.0003
149 ADENOVIRUS INFECTION 1 0.0003
150 NORMOCHROMIC NORMOCYTIC ANAEMIA 1 0.0003
151 VARICES OESOPHAGEAL 1 0.0003
152 EMBOLISM VENOUS 1 0.0003
153 FIBROSIS 1 0.0003
154 DIASTOLIC DYSFUNCTION 1 0.0003
155 APPLICATION SITE PAIN 7 0.0003
156 PNEUMONIA VIRAL 1 0.0003
157 FACET JOINT SYNDROME 1 0.0003
158 DEAFNESS NEUROSENSORY 1 0.0003
159 NEAR DEATH EXPERIENCE 1 0.0003
160 SKIN INJURY 1 0.0003
161 CERVICAL VERTEBRAL FRACTURE 1 0.0003
162 AORTIC STENOSIS 1 0.0003
163 LOGORRHOEA 1 0.0003
164 NECROTISING FASCIITIS 1 0.0003
165 SKIN WEEPING 1 0.0003
166 GRAFT VERSUS HOST DISEASE 2 0.0003
167 MONOCYTE COUNT INCREASED 1 0.0003
168 HYPOPHOSPHATAEMIA 2 0.0003
169 PARANASAL SINUS DISCOMFORT 1 0.0003
170 OESOPHAGEAL DISORDER 1 0.0003
171 HAEMOLYSIS 2 0.0003
172 SENSATION OF HEAVINESS 1 0.0003
173 BACTERAEMIA 3 0.0003
174 OESOPHAGEAL CANDIDIASIS 1 0.0003
175 BLEPHARITIS 1 0.0002
176 ENURESIS 1 0.0002
177 APPLICATION SITE DISCOLOURATION 1 0.0002
178 APPLICATION SITE EXFOLIATION 1 0.0002
179 APPLICATION SITE IRRITATION 3 0.0002
180 EMBOLISM 2 0.0002
181 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
182 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
183 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
184 ABSCESS LIMB 1 0.0002
185 PURULENT DISCHARGE 1 0.0002
186 SHOULDER OPERATION 1 0.0002
187 HORDEOLUM 1 0.0002
188 OCULAR ICTERUS 1 0.0002
189 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
190 APPLICATION SITE ERYTHEMA 6 0.0002
191 PULMONARY FUNCTION TEST DECREASED 1 0.0002
192 GROIN PAIN 2 0.0002
193 BLOOD CREATINE INCREASED 1 0.0002
194 HAEMOLYTIC ANAEMIA 2 0.0002
195 HAEMOGLOBIN INCREASED 1 0.0002
196 NEPHROGENIC ANAEMIA 1 0.0002
197 HYPOMAGNESAEMIA 3 0.0002
198 PERFORMANCE STATUS DECREASED 1 0.0002
199 SKIN TIGHTNESS 1 0.0002
200 SKIN ABRASION 1 0.0002
201 FAECAL INCONTINENCE 1 0.0002
202 HYPERCHOLESTEROLAEMIA 2 0.0002
203 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
204 STAPHYLOCOCCAL SEPSIS 1 0.0002
205 DIABETIC NEUROPATHY 1 0.0002
206 ORGANISING PNEUMONIA 1 0.0002
207 IMMUNODEFICIENCY 3 0.0002
208 HYPERNATRAEMIA 1 0.0002
209 INITIAL INSOMNIA 2 0.0002
210 EYE DISCHARGE 2 0.0002
211 APLASTIC ANAEMIA 1 0.0002
212 SCRATCH 2 0.0002
213 SERUM FERRITIN INCREASED 1 0.0002
214 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
215 GINGIVITIS 1 0.0002
216 BLOOD BILIRUBIN INCREASED 5 0.0002
217 HYPERKERATOSIS 1 0.0002
218 MALNUTRITION 2 0.0002
219 SKIN INFECTION 2 0.0002
220 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
221 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
222 HYPERTONIA 1 0.0002
223 SKIN ATROPHY 1 0.0002
224 ENTEROCOLITIS 1 0.0002
225 HYPERVENTILATION 1 0.0002
226 HYPOVOLAEMIA 1 0.0002
227 HYPERTRIGLYCERIDAEMIA 1 0.0002
228 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
229 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
230 PLEURISY 1 0.0002
231 ODYNOPHAGIA 1 0.0002
232 HEARING IMPAIRED 1 0.0002
233 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
234 SCOLIOSIS 1 0.0002
235 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
236 THERAPEUTIC RESPONSE CHANGED 1 0.0002
237 LOWER LIMB FRACTURE 3 0.0002
238 CARDIAC FLUTTER 1 0.0002
239 ASPERGILLUS INFECTION 1 0.0002
240 PRODUCT FORMULATION ISSUE 1 0.0002
241 HAEMATOCRIT DECREASED 3 0.0002
242 UPPER LIMB FRACTURE 3 0.0002
243 POST-TRAUMATIC STRESS DISORDER 1 0.0001
244 BRONCHIECTASIS 1 0.0001
245 ULCER HAEMORRHAGE 1 0.0001
246 PRODUCT LABEL ISSUE 1 0.0001
247 JOINT EFFUSION 1 0.0001
248 LYMPHOEDEMA 1 0.0001
249 LARGE INTESTINE POLYP 1 0.0001
250 HYPERTRANSAMINASAEMIA 1 0.0001
251 RASH MACULAR 5 0.0001
252 DIALYSIS 2 0.0001
253 THERMAL BURN 1 0.0001
254 SINUS TACHYCARDIA 2 0.0001
255 RED BLOOD CELL COUNT DECREASED 4 0.0001
256 DERMATITIS BULLOUS 1 0.0001
257 FAECES SOFT 1 0.0001
258 RASH PUSTULAR 1 0.0001
259 ORAL DISORDER 1 0.0001
260 BLINDNESS TRANSIENT 1 0.0001
261 SENSITIVE SKIN 1 0.0001
262 SKIN HAEMORRHAGE 2 0.0001
263 STEVENS-JOHNSON SYNDROME 3 0.0001
264 HAEMODYNAMIC INSTABILITY 1 0.0001
265 FOOD ALLERGY 1 0.0001
266 APHTHOUS ULCER 1 0.0001
267 HAEMORRHAGIC STROKE 1 0.0001
268 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
269 AFFECTIVE DISORDER 1 0.0001
270 HAEMOGLOBIN DECREASED 13 0.0001
271 FURUNCLE 1 0.0001
272 HYPOTHYROIDISM 4 0.0001
273 DECUBITUS ULCER 1 0.0001
274 METASTASES TO BONE 2 0.0001
275 ESCHERICHIA INFECTION 1 0.0001
276 CYTOMEGALOVIRUS INFECTION 2 0.0001
277 EOSINOPHIL COUNT INCREASED 1 0.0001
278 HAEMODIALYSIS 1 0.0001
279 PSYCHOLOGICAL TRAUMA 1 0.0001
280 EXPOSURE VIA SKIN CONTACT 3 0.0001
281 MUSCLE STRAIN 1 0.0001
282 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
283 LYMPHOCYTE COUNT DECREASED 2 0.0001
284 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
285 RESPIRATORY RATE INCREASED 1 0.0001
286 PRURITUS 42 0.0001
287 UROSEPSIS 1 0.0001
288 NERVE COMPRESSION 1 0.0001
289 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
290 DEEP VEIN THROMBOSIS 7 0.0001
291 PANCYTOPENIA 6 0.0001
292 NEPHROPATHY 1 0.0001
293 FLANK PAIN 1 0.0001
294 SQUAMOUS CELL CARCINOMA 1 0.0001
295 RASH ERYTHEMATOUS 5 0.0001
296 ACUTE RESPIRATORY FAILURE 2 0.0001
297 VITAMIN D DEFICIENCY 1 0.0001
298 PHARYNGEAL SWELLING 1 0.0001
299 BODY TEMPERATURE DECREASED 1 0.0001
300 BLADDER DISORDER 1 0.0001
301 NEUTROPHIL COUNT INCREASED 1 0.0001
302 EUPHORIC MOOD 1 0.0001
303 VENTRICULAR EXTRASYSTOLES 1 0.0001
304 WEIGHT FLUCTUATION 1 0.0001
305 PRODUCT ODOUR ABNORMAL 1 0.0001
306 CYSTITIS 3 0.0001
307 POOR QUALITY SLEEP 2 0.0001
308 RASH PRURITIC 5 0.0001
309 FAECES DISCOLOURED 2 0.0001
310 SKIN LACERATION 1 0.0001
311 PULMONARY THROMBOSIS 1 0.0001
312 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
313 WOUND INFECTION 1 0.0001
314 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
315 RASH PAPULAR 2 0.0001
316 OCULAR DISCOMFORT 1 0.0001
317 BLOOD CALCIUM DECREASED 1 0.0001
318 APPLICATION SITE PRURITUS 2 0.0001
319 GASTRIC HAEMORRHAGE 1 0.0001
320 COVID-19 PNEUMONIA 1 0.0001
321 BLOOD IRON DECREASED 1 0.0001
322 RASH 36 0.0001
323 ADRENAL INSUFFICIENCY 1 0.0001
324 HYPERGLYCAEMIA 3 0.0001
325 SPINAL OPERATION 1 0.0001
326 ABASIA 2 0.0001
327 CYST 1 0.0001
328 PNEUMONIA ASPIRATION 2 0.0001
329 CELLULITIS 4 0.0001
330 HYPOPHAGIA 2 0.0001
331 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
332 INFUSION SITE PAIN 1 0.0001
333 ECZEMA 4 0.0001
334 ANHEDONIA 2 0.0001
335 DERMATITIS ATOPIC 4 0.0001
336 SARS-COV-2 TEST POSITIVE 1 0.0001
337 TACHYPNOEA 1 0.0001
338 APPLICATION SITE RASH 1 0.0001
339 MENTAL STATUS CHANGES 2 0.0001
340 MASS 1 0.0001
341 WOUND 2 0.0001
342 CARPAL TUNNEL SYNDROME 1 0.0001
343 HYPONATRAEMIA 4 0.0001
344 SKIN REACTION 1 0.0001
345 BLINDNESS UNILATERAL 1 0.0001
346 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
347 SEPTIC SHOCK 3 0.0001
348 CARDIOMYOPATHY 1 0.0001
349 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
350 THERAPY NON-RESPONDER 3 0.0001
351 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
352 DEVICE FAILURE 1 0.0001
353 OEDEMA PERIPHERAL 8 0.0001
354 HIP ARTHROPLASTY 1 0.0001
355 HYPOKALAEMIA 3 0.0001
356 DEVICE RELATED INFECTION 1 0.0001
357 MUSCULOSKELETAL CHEST PAIN 1 0.0001
358 ANKLE FRACTURE 1 0.0001
359 ACUTE MYELOID LEUKAEMIA 1 0.0001
360 SWOLLEN TONGUE 2 0.0001
361 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
362 DYSPHAGIA 6 0.0001
363 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
364 OBESITY 1 0.0001
365 RHINORRHOEA 4 0.0001
366 BLOOD POTASSIUM INCREASED 1 0.0001
367 BLOOD CREATININE INCREASED 4 0.0001
368 STAPHYLOCOCCAL INFECTION 2 0.0001
369 LEUKOPENIA 3 0.0001
370 SKIN DISORDER 2 0.0001
371 BLOOD UREA INCREASED 1 0.0001
372 FACE OEDEMA 1 0.0001
373 CANDIDA INFECTION 1 0.0001
374 HAEMATURIA 2 0.0001
375 PARANOIA 1 0.0001
376 ORTHOSTATIC HYPOTENSION 1 0.0001
377 LOCAL SWELLING 1 0.0001
378 SPEECH DISORDER 3 0.0001
379 EOSINOPHILIA 1 0.0001
380 INJURY 4 0.0001
381 HYPOXIA 2 0.0001
382 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
383 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
384 DRUG ERUPTION 1 0.0001
385 ISCHAEMIC STROKE 1 0.0001
386 THIRST 1 0.0001
387 GOUT 1 0.0001
388 LEUKOCYTOSIS 1 0.0001
389 OSTEOMYELITIS 1 0.0001
390 END STAGE RENAL DISEASE 1 0.0001
391 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
392 RESTLESSNESS 2 0.0001
393 THINKING ABNORMAL 1 0.0001
394 MIDDLE INSOMNIA 1 0.0001
395 EYE PAIN 3 0.0001
396 PHOTOPHOBIA 1 0.0001
397 DYSPNOEA EXERTIONAL 2 0.0001
398 BLOOD SODIUM DECREASED 1 0.0001
399 HYPOCALCAEMIA 1 0.0001
400 GASTRIC ULCER 1 0.0001
401 PULMONARY EMBOLISM 5 0.0001
402 HERPES ZOSTER 3 0.0001
403 INJECTION SITE SWELLING 4 0.0001
404 LETHARGY 3 0.0001
405 HERNIA 1 0.0001
406 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
407 HAEMORRHOIDS 1 0.0001
408 CHOKING 1 0.0001
409 SKIN FISSURES 1 0.0001
410 VISION BLURRED 7 0.0001
411 SINUS DISORDER 1 0.0001
412 CATARACT 3 0.0001
413 BLOOD PRESSURE ABNORMAL 1 0.0001
414 SPINAL FRACTURE 1 0.0000
415 PLEURAL EFFUSION 3 0.0000
416 RIB FRACTURE 1 0.0000
417 POLLAKIURIA 2 0.0000
418 KNEE ARTHROPLASTY 1 0.0000
419 SKIN EXFOLIATION 4 0.0000
420 RENAL FAILURE ACUTE 2 0.0000
421 PLATELET COUNT DECREASED 5 0.0000
422 HYPOAESTHESIA 7 0.0000
423 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
424 VAGINAL HAEMORRHAGE 2 0.0000
425 ACUTE KIDNEY INJURY 7 0.0000
426 FEBRILE NEUTROPENIA 3 0.0000
427 TACHYCARDIA 4 0.0000
428 DEHYDRATION 6 0.0000
429 TRANSAMINASES INCREASED 1 0.0000
430 HEART RATE IRREGULAR 1 0.0000
431 NO ADVERSE EVENT 8 0.0000
432 SKIN IRRITATION 2 0.0000
433 SKIN DISCOLOURATION 2 0.0000
434 SHOCK 1 0.0000
435 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
436 PALPITATIONS 5 0.0000
437 SLEEP DISORDER 3 0.0000
438 URTICARIA 7 0.0000
439 BLOOD PRESSURE FLUCTUATION 1 0.0000
440 LOCALISED INFECTION 1 0.0000
441 INJECTION SITE URTICARIA 1 0.0000
442 BRONCHITIS 3 0.0000
443 DRY EYE 2 0.0000
444 HAEMATEMESIS 1 0.0000
445 ILLNESS 4 0.0000
446 RASH GENERALISED 1 0.0000
447 DIPLOPIA 1 0.0000
448 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
449 MUSCULOSKELETAL PAIN 2 0.0000
450 BRADYCARDIA 2 0.0000
451 PYREXIA 13 0.0000
452 FEAR 1 0.0000
453 JAUNDICE 1 0.0000
454 PAIN OF SKIN 1 0.0000
455 FREQUENT BOWEL MOVEMENTS 1 0.0000
456 THROAT TIGHTNESS 1 0.0000
457 NEUTROPENIA 5 0.0000
458 PNEUMONITIS 1 0.0000
459 ANAEMIA 7 0.0000
460 GAIT DISTURBANCE 7 0.0000
461 PROCEDURAL PAIN 1 0.0000
462 ARTHROPATHY 2 0.0000
463 SEPSIS 4 0.0000
464 HAEMOPTYSIS 1 0.0000
465 DEMENTIA 1 0.0000
466 TARDIVE DYSKINESIA 1 0.0000
467 PAIN IN JAW 1 0.0000
468 MUSCULAR WEAKNESS 4 0.0000
469 URINARY TRACT INFECTION 6 0.0000
470 INTENTIONAL DOSE OMISSION 1 0.0000
471 HYPOTENSION 7 0.0000
472 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
473 LIVER FUNCTION TEST ABNORMAL 1 0.0000
474 DYSSTASIA 1 0.0000
475 ASCITES 1 0.0000
476 DISEASE PROGRESSION 4 0.0000
477 URINARY INCONTINENCE 1 0.0000
478 WHEEZING 2 0.0000
479 ARTHRALGIA 14 0.0000
480 BLOOD POTASSIUM DECREASED 1 0.0000
481 LACRIMATION INCREASED 1 0.0000
482 EPILEPSY 1 0.0000
483 FEELING HOT 2 0.0000
484 LIMB DISCOMFORT 1 0.0000
485 FEMUR FRACTURE 1 0.0000
486 ANXIETY 9 0.0000
487 NEUROPATHY PERIPHERAL 3 0.0000
488 DEPRESSION 7 0.0000
489 OSTEONECROSIS 1 0.0000
490 EYE DISORDER 1 0.0000
491 VISUAL ACUITY REDUCED 1 0.0000
492 ABDOMINAL PAIN 7 0.0000
493 FUNGAL INFECTION 1 0.0000
494 SYNCOPE 3 0.0000
495 DRY SKIN 4 0.0000
496 INJECTION SITE PRURITUS 2 0.0000
497 EYE PRURITUS 1 0.0000
498 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
499 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
500 ASTHENIA 11 0.0000
501 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
502 DELIRIUM 1 0.0000
503 COUGH 8 0.0000
504 HYPERKALAEMIA 1 0.0000
505 HEART RATE DECREASED 1 0.0000
506 DIZZINESS 14 0.0000
507 MOBILITY DECREASED 2 0.0000
508 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
509 PNEUMONIA 9 0.0000
510 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
511 PAIN 17 0.0000
512 CRYING 1 0.0000
513 CONSTIPATION 6 0.0000
514 PANIC ATTACK 1 0.0000
515 MUSCLE SPASMS 5 0.0000
516 AGITATION 2 0.0000
517 DYSURIA 1 0.0000
518 INJECTION SITE MASS 1 0.0000
519 HEPATIC FUNCTION ABNORMAL 1 0.0000
520 COLITIS 1 0.0000
521 BLOOD PRESSURE INCREASED 4 0.0000
522 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
523 BACK PAIN 6 0.0000
524 PLASMA CELL MYELOMA 1 0.0000
525 CHILLS 3 0.0000
526 INJECTION SITE BRUISING 2 0.0000
527 CARDIAC FAILURE CONGESTIVE 2 0.0000
528 PSORIATIC ARTHROPATHY 1 0.0000
529 DEVICE BREAKAGE 1 0.0000
530 NEUTROPHIL COUNT DECREASED 1 0.0000
531 FATIGUE 19 0.0000
532 CARDIAC ARREST 2 0.0000
533 CARDIO-RESPIRATORY ARREST 1 0.0000
534 ROAD TRAFFIC ACCIDENT 1 0.0000
535 ABDOMINAL DISCOMFORT 4 0.0000
536 OSTEOARTHRITIS 1 0.0000
537 HYPOACUSIS 1 0.0000
538 MENTAL DISORDER 1 0.0000
539 RENAL FAILURE 3 0.0000
540 INSOMNIA 6 0.0000
541 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
542 THROAT IRRITATION 1 0.0000
543 MEMORY IMPAIRMENT 3 0.0000
544 NEPHROLITHIASIS 1 0.0000
545 NASOPHARYNGITIS 4 0.0000
546 CHEST PAIN 4 0.0000
547 HYPERSENSITIVITY 4 0.0000
548 DECREASED APPETITE 5 0.0000
549 BREAST CANCER 2 0.0000
550 COGNITIVE DISORDER 1 0.0000
551 CARDIAC DISORDER 2 0.0000
552 FALL 7 0.0000
553 PRODUCTIVE COUGH 1 0.0000
554 MULTIPLE SCLEROSIS 1 0.0000
555 BLOOD GLUCOSE DECREASED 1 0.0000
556 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
557 HYPOGLYCAEMIA 1 0.0000
558 PAIN IN EXTREMITY 6 0.0000
559 HEART RATE INCREASED 2 0.0000
560 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
561 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
562 FLUID RETENTION 1 0.0000
563 HOSPITALISATION 3 0.0000
564 PERIPHERAL SWELLING 3 0.0000
565 INFLAMMATION 1 0.0000
566 ABDOMINAL DISTENSION 2 0.0000
567 NERVOUSNESS 1 0.0000
568 PARAESTHESIA 3 0.0000
569 NAUSEA 15 0.0000
570 HYPERTENSION 4 0.0000
571 OEDEMA 1 0.0000
572 TREMOR 3 0.0000
573 MEDICATION ERROR 1 0.0000
574 INFLUENZA 2 0.0000
575 WEIGHT DECREASED 5 0.0000
576 NECK PAIN 1 0.0000
577 BLISTER 1 0.0000
578 DYSPNOEA 10 0.0000
579 FLATULENCE 1 0.0000
580 EYE IRRITATION 1 0.0000
581 DIARRHOEA 11 0.0000
582 NASAL CONGESTION 1 0.0000
583 IRRITABILITY 1 0.0000
584 THERAPEUTIC RESPONSE DECREASED 1 0.0000
585 STOMATITIS 1 0.0000
586 CONDITION AGGRAVATED 5 0.0000
587 VERTIGO 1 0.0000
588 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
589 OFF LABEL USE 14 0.0000
590 HEADACHE 10 0.0000
591 LOSS OF CONSCIOUSNESS 2 0.0000
592 SWELLING FACE 1 0.0000
593 PRODUCT DOSE OMISSION 1 0.0000
594 INFUSION RELATED REACTION 1 0.0000
595 BLOOD PRESSURE DECREASED 1 0.0000
596 ERYTHEMA 3 0.0000
597 INJECTION SITE REACTION 1 0.0000
598 SKIN BURNING SENSATION 1 0.0000
599 INFECTION 2 0.0000
600 RESPIRATORY FAILURE 1 0.0000
601 DYSGEUSIA 1 0.0000
602 WEIGHT INCREASED 3 0.0000
603 EPISTAXIS 1 0.0000
604 HOT FLUSH 1 0.0000
605 UNEVALUABLE EVENT 1 0.0000
606 CHRONIC KIDNEY DISEASE 1 0.0000
607 INCORRECT DOSE ADMINISTERED 3 0.0000
608 DIABETES MELLITUS 1 0.0000
609 DRUG INEFFECTIVE 17 0.0000
610 VOMITING 6 0.0000
611 ARTHRITIS 1 0.0000
612 CARDIAC FAILURE 1 0.0000
613 THROMBOSIS 1 0.0000
614 CONFUSIONAL STATE 2 0.0000
615 RENAL IMPAIRMENT 1 0.0000
616 MYALGIA 2 0.0000
617 BALANCE DISORDER 1 0.0000
618 PRODUCT STORAGE ERROR 1 0.0000
619 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
620 MUSCULOSKELETAL STIFFNESS 1 0.0000
621 MALAISE 5 0.0000
622 COVID-19 2 0.0000
623 GASTROINTESTINAL DISORDER 1 0.0000
624 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
625 ADVERSE EVENT 1 0.0000
626 OROPHARYNGEAL PAIN 1 0.0000
627 PRODUCT USE ISSUE 2 0.0000
628 BLOOD GLUCOSE INCREASED 2 0.0000
629 CONTUSION 1 0.0000
630 ATRIAL FIBRILLATION 1 0.0000
631 SOMNOLENCE 2 0.0000
632 CHEST DISCOMFORT 1 0.0000
633 SINUSITIS 1 0.0000
634 DEATH 8 0.0000
635 THROMBOCYTOPENIA 1 0.0000
636 ASTHMA 1 0.0000
637 RHEUMATOID ARTHRITIS 1 0.0000
638 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
639 FEELING ABNORMAL 2 0.0000
640 EMOTIONAL DISTRESS 1 0.0000
641 INJECTION SITE ERYTHEMA 1 0.0000
642 HYPERHIDROSIS 1 0.0000
643 PSORIASIS 1 0.0000
644 PRODUCT DOSE OMISSION ISSUE 2 0.0000
645 DRUG DOSE OMISSION 1 0.0000
646 TOXICITY TO VARIOUS AGENTS 1 0.0000
647 CEREBROVASCULAR ACCIDENT 1 0.0000
648 ALOPECIA 1 0.0000
649 ABDOMINAL PAIN UPPER 1 0.0000
650 INJECTION SITE PAIN 1 0.0000